NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
2.660
+0.070 (2.70%)
Nov 5, 2024, 3:32 PM EST - Market open
NeurAxis Employees
NeurAxis had 19 employees as of December 31, 2023. The number of employees increased by 1 or 5.56% compared to the previous year.
Employees
19
Change (1Y)
1
Growth (1Y)
5.56%
Revenue / Employee
$119,319
Profits / Employee
-$782,985
Market Cap
18.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 19 | 1 | 5.56% |
| Dec 31, 2022 | 18 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Marinus Pharmaceuticals | 166 |
| Lyra Therapeutics | 88 |
| Ekso Bionics Holdings | 72 |
| bioAffinity Technologies | 14 |
| Cocrystal Pharma | 12 |
| Bullfrog AI | 11 |
| NanoViricides | 7 |
NRXS News
- 14 days ago - NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - GlobeNewsWire
- 6 weeks ago - NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - GlobeNewsWire
- 2 months ago - NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 - GlobeNewsWire
- 3 months ago - NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 - GlobeNewsWire
- 3 months ago - NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - NeurAxis Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure - GlobeNewsWire
- 5 months ago - NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript - Seeking Alpha